###### Statement of significance

An increasing body of experimental evidence suggests an association between sleep and neurodevelopmental disorders such as autism spectrum disorders (ASDs) and epilepsy/EEG paroxysmal abnormalities. Furthermore, a recent study has highlighted a possible link between the concurrence of these two disorders (AEP, Autism--Epilepsy phenotype) and mutations in the *KCNJ10* gene coding for the astrocytic potassium channel Kir4.1. This preliminary study reports on electrophysiological sleep features observed in children with ASD or AEP and gain-of-function mutations of Kir4.1, which can be used as possible biomarkers of Kir4.1 dysfunction in these disorders.

Introduction {#s1}
============

Autism--epilepsy phenotype (AEP) {#s2}
--------------------------------

Autism spectrum disorders (ASDs) are a broad group of neurodevelopmental disorders characterized by impaired communication and social interactions and repetitive and restrictive behaviors \[[@CIT0001]\] that begin in childhood, with a variable degree of severity, and are associated with variable impairments in cognitive functioning \[[@CIT0002]\]. Etiologies and neural alterations underlying ASD are not clear and are still highly debated \[[@CIT0003]\].

ASDs are strongly associated with epilepsy and/or paroxysmal EEG abnormalities. Epidemiologically, people with ASD (especially females with lower verbal and nonverbal abilities \[[@CIT0008]\]) have a significantly higher risk of developing epilepsy, with a prevalence ratio of around 30%; conversely ASD features can be found in 5% of patients suffering from epilepsy \[[@CIT0008], [@CIT0009]\]. Yet, individuals with autism and comorbid epilepsy have lower intellectual, speech, and language abilities as compared to those without epilepsy \[[@CIT0008]\].

The relationship between ASD and epilepsy/paroxysmal EEG abnormalities has long been known, but common pathophysiological aspects have only recently been systematically described \[[@CIT0010]\] in a subgroup of individuals displaying AEP \[[@CIT0011], [@CIT0012]\].

Astrocytic Kir4.1 channels gain-of-function defects are related to autism--epilepsy comorbidity {#s3}
-----------------------------------------------------------------------------------------------

A recent study \[[@CIT0011]\] has revealed that the dysfunction of the astrocytic inwardly-rectifying potassium channels Kir4.1 (encoded by the *KCNJ10* gene) represents a possible pathogenic mechanism contributing to ASD and epilepsy comorbidity. Three *KCNJ10* gain-of-function (GoF) mutations (p.R18Q, p.V84M, and p.R348H) have showed a significant correlation with a relatively benign outcome of seizures, lower frequency of stereotyped behaviors, and greater alteration of sensory perception in AEP children.

In vitro studies \[[@CIT0013]\] clarified the effects of Kir4.1 mutations on channel function: p.R18Q mutation (the most frequent variant found in AEP patients) resulted in an increase in channel expression on astrocytic membranes, whereas the rarer p.R348H and p.V84M variants were instead associated with lower sensitivity to intracellular acidification and increased single channel conductance, respectively. The gain of Kir4.1 function ultimately led to an increase in K^+^ buffering by astrocytic cells, especially when exposed to high extracellular K^+^ concentration.

K^+^ buffering in astrocytes is an essential mechanism for the maintenance of optimal extracellular K^+^ concentration and consequently represents a crucial process for correct synaptic functioning \[[@CIT0018]\] and regulation of neuronal excitability \[[@CIT0021]\]. Kir4.1 activity at the tripartite synapse also plays an important role in *synaptic plasticity* by mediating neurovascular coupling \[[@CIT0022]\] and promoting synaptic maturation and remodeling \[[@CIT0023]\] that occur during sleep and across neurodevelopment. Altered synaptic homeostasis due to dysfunction of the Kir4.1 channel may therefore contribute to epileptic seizures and to cognitive and behavioral deficits \[[@CIT0024], [@CIT0025]\].

Sleep and AEP {#s4}
-------------

A high prevalence of sleep disorders has been found in ASD patients with significant consequences on daytime behavior \[[@CIT0026], [@CIT0027]\] and overall quality of life and a major impact on externalizing symptoms \[[@CIT0010]\]. Among the most commonly reported sleep problems, initial, intermediate, and terminal insomnias, and different parasomnias such as sleepwalking, REM sleep disorders, and sleep paralysis are described \[[@CIT0025], [@CIT0026]\]. Also, epilepsy and sleep have a significant mutual influence, such that sleep states can affect epilepsy, and in turn epilepsy can affect sleep \[[@CIT0028], [@CIT0029]\]. Indeed changes in membrane potential and in ion channels activity at the cellular level that occur in wakefulness-to-sleep transitions constitute a fertile ground for the expression of epileptic phenomena \[[@CIT0029]\]. Moreover, sleep deprivation has a strong epileptogenic effect especially in association with physical or emotional stress. Finally, seizures and anticonvulsant therapy can alter sleep architecture \[[@CIT0028], [@CIT0030]\].

Within sleep deepening, while cerebral cortex disconnects from the external environment, the most distinctive electrophysiological feature is the occurrence of slow waves (0.5--4 Hz) in all or most cortical areas \[[@CIT0031]\]: they are negative deflections followed by positive peaks, which cross the *x*-axis with a certain inclination \[[@CIT0032]\].

Every wave originates in small different regions of the cortex and travels uniquely to other cortical areas with its own speed and pattern of propagation, often originating in anterior cortical regions and propagating throughout the mesial highway to posterior regions \[[@CIT0032], [@CIT0033], [@CIT0035]\].

Slow waves are the consequence of the activity of million bistable neurons around cortical layer 5 \[[@CIT0036], [@CIT0037]\] that nearly every second (\<1 Hz) \[[@CIT0035]\] generate synchronized membrane potentials slow oscillations, from hyperpolarized "down-states" during which neurons remain silent for a few hundred milliseconds, to "up-states" characterized by prolonged depolarization and irregular firing \[[@CIT0038]\]. Mechanisms that trigger and terminate up- and down-states remain unclear, but the importance of depolarization-dependent K^+^ currents \[[@CIT0042], [@CIT0043]\] is wellknown: since K^+^ is necessary to modulate neuronal excitability both at the presynaptic and postsynaptic levels, the ability of neuroglia to buffer local increases of extracellular K^+^ confer to these cells an active role in the modulation and spreading of cortical oscillatory activities \[[@CIT0044]\].

Changes in slow wave parameters point out changes in synchrony of neuronal firing which in turn reflect changes in synaptic strength and efficiency of cortico-cortical connections \[[@CIT0033], [@CIT0045], [@CIT0046]\]. While slow wave amplitude correlates to the number of neurons entering synchronously in the up- or down-state, slow wave slope reflects the speed of neuronal recruitment \[[@CIT0041], [@CIT0043]\]. Thus, slow waves amplitude and slope act as indirect but reliable EEG markers of circuit dynamics, which in turn may be expression of synaptic plasticity \[[@CIT0033], [@CIT0042], [@CIT0047], [@CIT0048]\].

During neuronal development, changes in slow wave parameters reflect unique aspects of brain connectivity and adaptation during synaptic maturation \[[@CIT0046], [@CIT0049], [@CIT0050]\]. Throughout adolescence, a progressive weakening of short-range connections occurs in association with a strengthening of long-range ones \[[@CIT0051]\], resulting in a significant decline of the slow wave activity (SWA) \[[@CIT0052]\].

Instead, in individuals with autism, circuits involving nearby neurons are more frequently activated than those involving neurons among distant cortical areas \[[@CIT0055]\], so that the former would be consolidated while the latter would have been lost permanently \[[@CIT0056]\]. This impairment of down-selection during critical developmental periods could have irreversible consequences on wiring and function of neural circuits \[[@CIT0057]\] and could reflect in major sleep abnormalities \[[@CIT0027], [@CIT0046]\].

Altered sleep-wake cycles have implications on astrocytic plasticity, too \[[@CIT0023], [@CIT0061], [@CIT0062]\]. Astrocytes are responsive to changes in wake-promoting neuromodulators, not only by regulating extracellular volume but also by influencing composition and glymphatic drainage of interstitial fluid. These events are accompanied by changes in astrocyte--neuron interactions and neurovascular coupling, synaptic maturation and remodeling, and especially neuronal discharge patterns \[[@CIT0063]\]. Reduced astrocytic coverage during sleep may favor glutamate spill-over and increase K^+^ buffering, which promote neuronal synchronization during NREM sleep \[[@CIT0061], [@CIT0063], [@CIT0064]\] and characterize EEG slow wave sleep pattern \[[@CIT0021], [@CIT0044], [@CIT0065]\].

In this study, we compared several parameters of slow waves in a group of seven mutated children and in seven sex- and age-matched control subjects, to test our hypothesis that a well characterized mutation in Kir4.1 channels and consequent and persistent K^+^ buffering could result in specific electrophysiological features of sleep (amplitude, period, and down and up slope), paving the way to the discovery of potentially clinically relevant biomarkers that may help in distinguishing children with ASD/AEP and GoF mutations of astrocytic Kir4.1 channel from those with similar phenotypes but no Kir4.1 dysfunction.

Methods {#s5}
=======

Subjects {#s6}
--------

Fourteen subjects with ASD were included in the present study, 12 males and 2 females ranging from 3 to 13 years of age (8.25 mean ± 3.54 SD). Twelve of them (10 males and 2 females) had a history of epileptic seizures and/or EEG abnormalities, and among them, 5 (4 males) were taking sodium valproate (VPA) during EEG recording. Seven subjects of our cohort (6 males), carried a GoF mutation of the Kir4.1 channel gene. Among them, the R18Q variant was found in 6 males, while the R348H variant was found only in one female. Mutated and control subjects were matched for phenotype, age, and gender ([Table 1](#T1){ref-type="table"}).

###### 

Sample characteristics

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ID       Gender:\      Age         Treatment at the time of the EEG under investigation   *KCNJ10*\   History of seizures\   Type of seizures   Seizure outcome                                 Eeg abnormalities\
           1=Fml, 2=Ml                                                                      mutation    0=No, 1=Yes                                                                               0=No, 1=Yes
  -------- ------------- ----------- ------------------------------------------------------ ----------- ---------------------- ------------------ ----------------------------------------------- --------------------
  **1**    2             12 years\   VPA                                                    R18Q        1                      absences           Remission\                                      1
                         8 months                                                                                                                 under VPA                                       

  **2**    2             13 years\   \-                                                     R18Q        0                                                                                         1
                         5 months                                                                                                                                                                 

  **3**    1             9 years\    \-                                                     R348H       1                      spasms             Spontaneous remission after a febrile illness   1
                         7 months                                                                                                                                                                 

  **4**    1             8 years\    VPA                                                    WT          1                      absences           Remission\                                      1
                         7 months                                                                                                                 under VPA                                       

  **5**    2             12 years\   VPA                                                    WT          1                      focal              Remission\                                      1
                         8 months                                                                                                                 under VPA                                       

  **6**    2             3 years\    \-                                                     R18Q        0                                                                                         0
                         8 months                                                                                                                                                                 

  **7**    2             3 years\    \-                                                     WT          0                                                                                         0
                         9 months                                                                                                                                                                 

  **8**    2             6 years\    \-                                                     R18Q        1                      Spasms + focal     Remission under ACTH, VPA, TPM                  1
                         3 months                                                                                                                                                                 

  **9**    2             6 years\    \-                                                     R18Q        1                      spasms             Remission\                                      1
                         0 months                                                                                                                 under ACTH and VPA                              

  **10**   2             5 years\    \-                                                     R18Q        0                                                                                         1
                         6 months                                                                                                                                                                 

  **11**   2             6 years\    VPA                                                    WT          1                      focal              Still active epilepsy                           1
                         4 months                                                                                                                                                                 

  **12**   2             6 years\    VPA                                                    WT          1                      tonic-clonic       Remission\                                      1
                         9 months                                                                                                                 under VPA                                       

  **13**   2             13 years\   \-                                                     WT          0                                                                                         1
                         3 months                                                                                                                                                                 

  **14**   2             5 years\    \-                                                     WT          0                                                                                         1
                         8 months                                                                                                                                                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ID= identification number; Fml= female; Ml= male; VPA= sodium valproate; WT= Wild Type.

Recruitment criteria {#s7}
--------------------

A cohort of children with ASD/AEP was recruited at the Stella Maris Foundation Hospital from 2009 to 2017. Among them, subjects with a history of seizures and/or EEG abnormalities were included in the autism--epilepsy phenotype subgroup.

Phenotype characterization was carried out through clinical and laboratory assessments, EEG study, and brain magnetic resonance imaging. A family history for epilepsy or ASD was investigated up to the 4th degree of kinship. Clinical and EEG assessments, and *KCNJ10* sequencing, were performed after having obtained an informed consent from parents or caregivers, and complying with the ethical principles outlined by the Declaration of Helsinki.

EEG recording and sleep scoring {#s8}
-------------------------------

Digital video-EEG-polysomnographic (PSG) systems (Grass Technologies, Rhode Island, United States; Micromed, Mogliano Veneto, Italy) were used to obtain sleep recordings in children during 1-h-long daytime naps on average ([Table 2](#T2){ref-type="table"}). PSG measurements included 19 electrodes EEG in a standard 10--20 location, deltoid muscle electromyogram (EMGs), and electrocardiogram (ECG).

###### 

Sleep measures for entire nap

                                Wild-Type       Mutated         *P*-value
  ----------------------------- --------------- --------------- -----------
  Total time in bed, min        54.14 ± 3.776   60.57 ± 3.884   0.258
  Total sleep time (TST), min   24.71 ± 2.286   22.00 ± 2.177   0.407
  NREM1, min                    1.64 ± 0.497    1.86 ± 0.652    0.798
  NREM2, min                    8.57 ± 1.706    8.86 ± 2.593    0.928
  NREM3, min                    13.50 ± 3.677   10.43 ± 2.494   0.503
  Waking period                 1.36 ± 0.322    0.86 ± 0.210    0.218

Data are expressed as mean ± SEM (*n* = 7). Two subjects do not have NREM 3 sleep stage. None of all presents REM sleep stage.

min, minutes; NREM, nonrapid eye movement; SEM, standard error of the mean; *n*, number of subjects per group.

Sleep recordings were scored by a trained scorer according to *American Academy of Sleep Medicine* (AASM) standardized criteria \[[@CIT0028]\]: Alice Sleepwear software was used for manual visual epoch-by-epoch scoring on 30-s-long segments of neurologic layout of PSG channels.

Slow wave detection and analysis of wave parameters {#s9}
---------------------------------------------------

For slow wave sleep detection a single EEG signal channel was used, as performed in a recent study \[[@CIT0066]\]. The choice was based both on methodological and electrophysiological rationales. Each derivation was preliminarily assessed for every subject. For each derived signal we performed temporal and spectral analyses and a score, from 0 to 10, was then assigned to judge the quality and cleanliness of each subject's signal. Thus, for each signal, the scores ranged from 0 to 140 given that there were 14 subjects in total. F3-C3 (107 points), F4-C4 (103 points) and Fz-Cz (108 points) were the most eligible channels for evaluation. First, the Fz-Cz channel was selected since it was the one with few artifacts and the most evident waves and it is considered the most suitable for evaluating slow waves \[[@CIT0067], [@CIT0068]\]; then, to enrich the dataset and support the results, the same analyses were also re-run separately for F3-C3 and F4-C4 since they were of almost equivalent quality and equivalent artifacts-free.

Sleep slow waves were automatically detected using a re-edited EEGLAB toolbox (MatLab, The Math Works Inc., Natick, MA). First, 200 Hz sampled signal was high-pass filtered (0.1 Hz) and band-pass filtered (0.3--30 Hz) to remove artifacts and background noise. Second, using a Chebyshev Type II filter (band-pass 0.5--4.0 Hz, stopband 0.1 and 10 Hz) signal was re-filtered for slow wave best detection. The filter parameters were visually optimized on the EEG signal to achieve minimal wave shape and amplitude distortion while allowing the least high-frequency contamination.

Finally, individual half-waves were detected by defining a half-wave as negative deflections between 2 zero-crossings \[[@CIT0069]\]. The zero-crossing detection was chosen for the analysis due to the high degree of variability in the positive signal deflections compared to the stability of the negative deflections.

Within an artifact- and epileptic abnormalities-free NREM epoch, only half-waves whose period and maximal negative amplitude were bigger than the mode of all half-waves detected were considered as slow waves.

The use of the mode as a threshold was empiric, carefully assessed by analyzing each subject after applying the same criteria. The mode was assessed for period and amplitude as the highest peak of a histogram, which in turn is the frequency distribution in classes of a parameter.

Moreover, to assess whether differences in slow wave amplitude are related to difference in slow wave period, we detected sleep slow waves based only on a duration criterion, for instance, 0.25--1 s negative-to-positive zero crossing.

This detection procedure described above has been found to be similar to that employed in a previous work on period-amplitude analysis \[[@CIT0033], [@CIT0070]\] and allowed a specific detection of slow waves during NREM2 and NREM3 stages sleep. Identified slow waves were then plotted to visually assess the reliability of the automatic detection for each subject.

For every detected slow oscillation, we collected several single-wave parameters that could be used to compare the two groups: (1) half-waves number, (2) half-waves period, (3) amplitudes of the maximal negative peaks, and (4) maximal half-wave down and up slope. Maximal slopes were defined as the maximum of the signal derivative following the negative zero crossing but before the most negative peak (down slope), or after the most negative peak but prior to the positive-going zero crossing (up slope).

To improve slow waves detection and to avoid detection of large epileptic waves like slow waves (EEG abnormalities highlighted in 12/14 subject, 64.29%), MatLab scripts have been implemented based on a previous work by Dr. Brady Riedner of University of Wisconsin (Madison, WI) \[[@CIT0033]\] ([Figure 1](#F1){ref-type="fig"}).

![Slow waves detection. A MatLab® EEG plot of a NREM3 sleep epoch is here reported. Amplitude detected half-slow waves are highlighted with a thick black line, whereas the background rhythm is marked with a fine one. Half-waves were defined as negative deflections between 2 zero-crossings. Slow waves were automatically detected using MatLab EEGLAB toolbox, editing a previous detection algorithm described by Riedner et al. \[[@CIT0033]\].](zsz255f0001){#F1}

Finally, since the vast majority of the recorded waves had an amplitude \<100 µV (95.76% of *wild-type* subjects' waves, 98.32% of mutated subjects' ones), we focused on slow wave parameters within this amplitude range and subdivided detected waves showing an amplitude \<100 µV into 10 groups of 10 µV of width.

However, since subject 13's data showed multiple artifactual epileptic graphoelements that affected the majority of the EEG tracing, we excluded subject 13 and the paired control subject 2 from the analysis of slow waves.

Statistical analysis {#s10}
--------------------

Statistical analyses were performed using Sigma Plot software to compare ASD/AEP children with astrocytic Kir4.1 mutated channels to a control group of ASD/AEP wild-type (WT) children.

Each comparison was performed between all mutations and all WT, then between mutated and WT subgroups matched by age, to evaluate the specific effect of this variable on sleep.

For each parameter, comparisons were first performed between the two groups of mutated and WT children; then, age- and sex-matched pairs of mutated and WT children were individually compared to estimate the effect size of related clinical variables.

A nonparametric Mann--Whitney U-test was performed to assess differences in slow wave parameters. Finally, to take into account the effect of potential confounders, we estimated longitudinal linear regression using two different methods: random-effects (RE) and generalized estimating equations (GEE) models.

Results {#s11}
=======

First, we compared total sleep and sleep stage durations between mutated children group and controls ([Table 2](#T2){ref-type="table"}).

There were no significant differences in total time in bed, total sleep time (TST), NREM1, NREM2, NREM3 and in waking epochs occurring during nap, between WT and mutated subjects.

Astrocyte Kir4.1 channel mutation is associated with longer slow waves period {#s12}
-----------------------------------------------------------------------------

In order to examine changes in individual slow wave parameters between WT and mutated subjects, we analyzed a statistically comparable number of automatically detected slow waves in the Fz-Cz derivation (median number of detected slow waves in mutated subjects = 1724 versus median number of detected slow waves in control subjects = 1309.5, Wilcoxon Test *p*-value = 0.313). A significant difference was observed in the period of the half-negative waves between cases and controls. First, we found that the slow waves period in mutated subjects was longer than the wild types' one (mean period = 112,617 ms ± SE = 0.465 in mutated versus mean period = 105,249 ms ± SE = 0.375 in controls, *p* \< 0.001). Then, age- and sex-matched pairs of mutated and WT children, ranging from 3 to 13 years, were created to compare sleep slow waves parameters and avoid confounding factors due to changes across neurodevelopment ([Figure 2](#F2){ref-type="fig"}).

![Slow wave period in a case--control analysis. (**A**) Period (ms) is shown on *y*-axis. WT (*n* = 10,390 waves) bar is reported in anthracite/black while M (*n* = 7,696 waves) one is in gray. Error bars are also represented. (**B**) Period (ms) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Mutated subjects have slow waves with longer periods than WT and also in all age-matched comparisons differences are greater than would be expected by chance. \**p* \< 0.05; \*\**p* \< 0.001; WT, wild type; M, mutated; ms, milliseconds; *n*, number of waves.](zsz255f0002){#F2}

For each couple we normalized the interval duration of detection window of slow waves on the shortest one between the two subjects within the couple. So, a difference in slow wave form is shown between cases and controls ([Figure 3](#F3){ref-type="fig"}).

![Wave forms. Here is a graphical representation of the comparison between the average waveform in WT children (anthracite/black) and the average waveform in Kir4.1-mutated children (gray). Period (ms) and amplitude (μV) are, respectively, shown on the *x*-axis and on the *y*-axis. The standard errors are also shown for mean amplitude of the negative peaks, mean time of the negative peaks and mean period.](zsz255f0003){#F3}

Also, we found that the difference between mutated and WT subjects is further enhanced in the range from −10 µV to −40 µV. Within this range, the period was significantly longer in subjects with astrocyte Kir4.1 mutated channels compared to controls. Conversely, higher amplitude slow waves have shown no statistically significant difference between cases and controls ([Figure 4](#F4){ref-type="fig"}).

![Slow wave period in an amplitude-dependent case--control analysis. (**A**) Amplitude (μV) and period (ms) are, respectively, shown on *x*-axis and *y*-axis. WT bars are reported in anthracite/black while M bars are in gray. Error bars are represented, too. We analyzed the trend of the period according to amplitude of the maximal negative peaks of the detected half- slow waves. We analyzed the data by evaluating an amplitude range between 0 and 100 μV in which the greatest number of waves is recorded (as shown in **B**). This range has been further subdivided into subranges of 10 μV. We found statistically significant differences between the two groups in the ranges between 0 and 40 μV and from 50 μV to 60 μV. \* *p* \< 0.05; \*\* *p* \< 0.001; WT, Wild Type; M, mutated; ms, milliseconds; μV, microvolts; Wvs N, waves number.](zsz255f0004){#F4}

An analogue result was obtained for F3-C3 (mean period = 125,706 ms ± SE = 0.397 in mutated versus mean period = 120,872 ms ± SE = 0.472 in controls, *p* \< 0.001) and F4-C4 (mean period = 127,914 ms ± SE = 0.557 in mutated versus mean period = 118,174 ms ± SE = 0.442 in controls, *p* \< 0.001) ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}).

![Slow wave period in a case--control analysis; F3-C3 derivation. (**A**) Period (ms) is shown on *y*-axis. WT (*n* = 7,740 waves) bar is reported in anthracite/black while M (*n* = 13,346 waves) one is in gray. Error bars are also represented. (**B**) Period (ms) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Mutated subjects have slow waves with longer periods than WT and also in all age-matched comparisons differences are greater than would be expected by chance. \* *p* \< 0.05; \*\* *p* \< 0.001; WT, wild type; M, mutated; ms, milliseconds; *n*, number of waves.](zsz255f0005){#F5}

![Slow wave period in a case--control analysis; F4-C4 derivation. (**A**) Period (ms) is shown on *y*-axis. WT (*n* = 9,217 waves) bar is reported in anthracite/black while M (*n* = 7,028 waves) one is in gray. Error bars are also represented. (**B**) Period (ms) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Mutated subjects have slow waves with longer periods than WT and also in all age-matched comparisons differences are greater than would be expected by chance. \* *p* \< 0.05; \*\* *p* \< 0.001; WT, wild type; M, mutated; ms, milliseconds; *n*, number of waves.](zsz255f0006){#F6}

Astrocyte Kir4.1 channel mutation is not associated with other changes in slow waves parameters {#s13}
-----------------------------------------------------------------------------------------------

Similarly, we analyzed down and up slope of slow waves detected in Fz-Cz signals, both between groups and among age-matched couples. Significant differences emerged in slow wave slopes between age-matched couples of mutated and WT subjects (mean down-slope = 500,669 μV/ms ± SE = 3.643 in mutated versus mean down-slope = 519,857 μV/ms ± SE = 4.306 in controls, *p* ≤ 0.001; mean up-slope = 493,835 μV/ms ± SE = 3.591 in mutated versus mean up-slope = 491,824 μV/ms ± SE = 3.644 in controls, *p* ≤ 0.001); however, the distribution of slow waves slopes mean values is highly variable depending on the age and no meaningful trend is observed between cases and controls ([Figures 7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}).

![Down-slope in a case--control analysis. (**A**) Down-slope (μV/ms) is shown on *y*-axis. WT (*n* = 10,390 waves) bar is reported in anthracite/black while M (*n* = 7,696 waves) one is in gray. Error bars are also represented. (**B**) Down-slope (μV/ms) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Using Mann--Whitney rank-sum test we found statistically significant differences between slow waves. Down-slopes of every subject with mutated Kir4.1 channels compared with its own WT control matched by age. \*\**p* \< 0.001; WT, wild type; M, mutated; ms, milliseconds; μV, microvolts; *n*, number of waves.](zsz255f0007){#F7}

![Up-slope in a case--control analysis. (**A**) Up-slope (μV/ms) is shown on *y*-axis. WT (*n* = 10,390 waves) bar is reported in anthracite/black while M (*n* = 7,696 waves) one is in gray. Error bars are also represented. (**B**) Up-slope (μV/ms) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Using Mann--Whitney Rank Sum Test we found statistically significant differences between slow waves Down-slopes of every subject with mutated Kir4.1 channels compared with its own WT control matched by age. \*\**p* \< 0.001; WT, wild type; M, mutated; ms, milliseconds; μV, microvolts; *n*, number of waves.](zsz255f0008){#F8}

In the end, although we found that in the fronto-central medial bipolar derivation (Fz-Cz) the overall mean of slow waves amplitude was significantly higher in mutated subjects than controls, the result does not reflect a marked difference between the slow waves amplitudes detected in KCNJ10 mutated and WT subjects (mean amplitude = −30,371 μV ± SE = 4.4282 in mutated versus mean amplitude = −27,854 μV ± SE = 7.167 in controls, *p* ≤ 0.001) and no meaningful trend is observed between cases and controls across ages ([Figure 9](#F9){ref-type="fig"}).

![Amplitude case--control analysis. (**A**) Amplitude (µV) is shown on *y*-axis. Wild Type (WT, *n* = 10,390 peaks) bar is reported in anthracite/black while mutated (M, *n* = 7,696 peaks) is in gray. Error bars are also represented. Amplitude evaluation in a stand-alone manner shows a statistically significant difference between the 2 groups. (**B**) Amplitude (μV) is shown on *y*-axis. WT box-plots are reported in anthracite/black while M ones are in gray. Using Mann--Whitney rank-sum test we found statistically significant differences between slow waves Amplitudes of every subject with mutated Kir4.1 channels compared with its own WT control matched by age. \*\**p* \< 0.001; WT, wild type; M, mutated; μV, microvolts; *n*, number of waves.](zsz255f0009){#F9}

The results seem to be confirmed also estimating longitudinal linear regression using both the RE and GEE methods ([Table 3](#T3){ref-type="table"}).

###### 

Longitudinal linear regression estimation using both the RE and GEE methods

               Crude (RE)   Adjusted (RE)   Crude (GEE)   Adjusted (GEE)
  ------------ ------------ --------------- ------------- ----------------
  Amplitude    0.834        0.827           0.819         0.773
  Down-slope   0.816        0.753           0.799         0.690
  Up-slope     0.814        0.810           0.796         0.756
  Period       0.037        0.025           0.022         0.015

In this table, the *p*-values associated to subjects with mutated KCNJ10 are shown. Two models have been made: one "Crude" including only KCNJ10, and one "Adjusted" in which gender, age and VPA were also included.

RE, random effects model; GEE, generalized estimating equations model; VPA, sodium valproate.

Discussion {#s14}
==========

Our study aimed at evaluating electrophysiological features of sleep in a cohort of ASD/AEP children with GoF mutation of the astrocytic Kir4.1 channel, compared to age- and sex-matched children with similar phenotypes, but not carrying Kir4.1 mutations. Although the ASD/AEP children cohort was small, subjects were recruited over a long period of time (from 2009 to 2017) and are the only ones who are recognized---at least to date---to have an association between ASD/AEP and GoF mutation of the astrocytic Kir4.1 channels. This study, to the best of our knowledge the first investigating sleep EEG features in this cohort, reveals that the slow waves detected in sleep EEG recordings during daytime naps behave differently when associated with mutations in Kir4.1 channels and consequent dysfunction of astrocytic K^+^ buffering \[[@CIT0011]\]. Subjects with Kir4.1 mutations have indeed a significantly longer slow waves period than controls. This difference, which is particularly relevant for slow waves in the low-amplitude range, appears to be independent from the developmental stage since it remains stable from childhood to adolescence, thus providing a potential electrophysiologically grounded noninvasive biomarker for these mutations.

One might further speculate on the pathogenic mechanism underlying these alterations. Indeed, the local increase in extracellular K^+^ has an active role in the homeostasis of neuronal excitability \[[@CIT0021], [@CIT0044]\] but the mutations of *KCNJ10* might prevent this increase by favoring a strongest or more continuous K^+^ buffering that is collected from astrocytes and carried to other distant brain areas \[[@CIT0020]\].

Therefore, in subjects with mutated Kir4.1 channels the increase in period duration might reflect a longer time during slow wave sleep in a state of hyperpolarization (down-state) which is in turn reflected by a longer negative half-wave period \[[@CIT0071]\]. This difference becomes more evident when a small number of neurons is recruited in the oscillatory activities resulting in small amplitude slow waves \[[@CIT0045], [@CIT0046]\], which are proportionally more sensitive to changes in the extracellular ions concentration.

Thus, the period of slow waves, which is generally modulated by extracellular factors such as the persistent Na^+^ current and the depolarization-activated K^+^ current \[[@CIT0033]\], could be reliably detected in ASD/AEP children carrying GoF Kir4.1 mutations.

Moreover, we could not find any difference between mutated and WT subjects in the slow wave down and up slopes. This is likely due to the evidence that slow wave slope is deeply influenced by the synaptic strength while being less affected by the surrounding extracellular environment \[[@CIT0033], [@CIT0047]\], notably the extracellular K^+^ concentration, mostly in the high-amplitude range of slow waves \[[@CIT0033], [@CIT0041], [@CIT0043]\]: in fact, slow waves amplitude is supposed to be closely linked to the number of neurons recruited in slow oscillations between up and down states \[[@CIT0041], [@CIT0043]\]. In other words, the greater the number of neurons recruited in the oscillation, the lower the influence of extracellular ion concentration changes on slow wave amplitude; on the other hand, with fewer recruited neurons, changes in astrocyte K^+^ buffering activity is proportionally more influential.

Finally, high variability was found also in the average of slow waves amplitude, and no meaningful trend was observed between mutated and WT subjects. The lack of any statistical difference between cases and controls in terms of slow wave parameters other than the period supports the specificity and distinctive role of this electrophysiological feature in the discrimination between mutated and WT subjects.

Furthermore, we could not detect any significant difference between groups in TST, sleep stage duration, and other macrostructural sleep parameters. This further supports the hypothesis that period-amplitude differences in slow wave sleep parameters between cases and controls are likely due to the specific genetic pattern, and consequent K^+^ buffering efficiency, but not to differences in sleep time measures.

Our preliminary results have promising clinical implications since they provide a useful biomarker of Kir4.1 dysfunction in ASD/AEP children harboring *KCNJ10* mutations in brief EEG recordings of daytime naps, without needing therefore prolonged EEG monitoring of the sleep. This would avoid the commitment of both medical equipment and technical and health personnel for the entire duration of night EEG recording to highlight sleep disturbance and confirm the phenotype.

The main limit of our study remains the small size of our sample. However, an appropriate statistical approach was used to avoid type 1 errors. We also remark that our sample was heterogeneous with respect to current symptoms and medications which could create a bias effect in data analysis. As an example, improved Kir4.1 function may decrease seizure propensity \[[@CIT0011], [@CIT0012], [@CIT0072]\] and the precise history of seizures could also lead to major changes in synaptic plasticity that may possibly explain the differences observed. We were aware that there were some differences in the two groups analyzed, for instance one patient in the control group (ID 11) still had active epilepsy at the time of the EEG, while all those with Kir4.1 mutations were under remission. Nevertheless, we did our best to match the samples with regard to gender, age, and clinical histories in order to minimize possible biases due to nongenetic features.

Furthermore, the results obtained after evaluating the longitudinal linear regression using both the RE and GEE methods are also quite similar and suggest no significant differences for down slope, up slope and amplitude: intuitively, for these parameters, the differences shown in [Figures 7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"} and [9](#F9){ref-type="fig"} could be explained by systematic differences between individuals, whereas a KCNJ10 mutation would not be an important predictor. On the contrary, this is not true for the period, which is confirmed to be significantly influenced by the presence of this mutation ([Table 3](#T3){ref-type="table"}).

We also tested the strength of the result in the face of a different filter setting (1--3 Hz): re-performing the analyses with these subtle alterations in the choice of filters, we confirmed differences between cases and controls for period (mean period = 130,720 ms ± SE = 0.418 in mutated versus mean period = 124,515 ms ± SE = 0.412 in controls, *p*-value = \<0.001), down-slope (mean down-slope = 293,699 μV/ms ± SE = 2.354 in mutated versus mean down-slope = 304,718 μV/ms ± SE = 2.762 in controls, *p* = 0.003), Up-slope (mean up-slope = 302,264 μV/ms ± SE = 2.326 in mutated versus mean up-slope = 288,422 μV/ms ± SE = 2.731 in controls, *p* ≤ 0.001) and amplitude (mean amplitude = −23,707 μV ± SE = 4.552 in mutated versus mean amplitude = −22,851 μV ± SE = 6.108 in controls, *p* = 0.001).

Given the subtle nature of the results and the low number of subjects, we were careful to repeat the analyses, testing altered half-wave detection criteria too. In estimating longitudinal linear regression using the RE models for slow waves detected with three different setting thresholds, from the least inclusive to the most---mean, median and 95th percentile---we found that while amplitude, down-slope and up-slope are not influenced by the presence of the mutation, differences in the period between cases and controls seem to have a progressive tendency to significance from the mean ("Crude" model *p*-value = 0.824; "Adjusted" model *p*-value = 0.238) to the 95th percentile ("Crude" model *p*-value = 0.032; "Adjusted" model *p*-value = 0.039), and through the median ("Crude" model *p*-value = 0.191; "Adjusted" model *p*-value = 0.077). This is probably due to two reasons: mean and median are most affected by the distribution of values and above all, aberrant or extreme values of the distribution, with respect to the mode; in addition they are less inclusive criteria and many of the waves on which the difference between mutated and wild type is played, are excluded. Similar results were obtained across all fronto-central derivations (Fz-Cz and also F3-C3, F4-C4, data not shown).

The differences in slow wave features should be confirmed by further studies on larger samples of affected subjects in order to verify the reproducibility, specificity, sensitivity and robustness of the present results. ASD and epilepsy are very common worldwide and are clinically important and relevant for public health and socioeconomic burden.

Moreover, sleep has recently emerged as a potential marker of autism and other neurodevelopmental disorders and a close association between epilepsy and sleep has been repeatedly confirmed; sleep disorders could be so relevant that they might play a causal role in the development of some neuropsychiatric disorders.

Specific sleep abnormalities, repeatedly reported in ASD patients with an epileptic phenotype both clinically and polysomnographically, may play a role for diagnostic purposes.

In our case--control study between ASD/AEP children with mutations of *KCNJ10* gene (coding for potassium channels Kir4.1 abundantly expressed in astrocytes) and a control group consisting of children WT for the same gene and similar clinical phenotypes, we compared characteristic parameters of slow waves detected during daytime sleep EEG recordings.

Our hypothesis was that astrocytic Kir4.1 channels GoF mutations and consequent dysfunctional and persistent K^+^ buffering could influence neurons activity, slowing down the achievement of their action potential.

This abnormality underlies changes in slow waves features and particularly in period, which is longer in subjects with *KCNJ10* mutations compared to WT. This difference in slow wave features could have interesting clinical implications. Evaluation of a short period of a daytime nap is sufficient and more compatible with clinic practice than an entire night sleep recording, providing an instrumental and therefore objective diagnostic support.

The peculiar electrophysiological features of sleep slow waves identified in Kir4.1 mutated children could represent a clinically relevant readout of astrocytic dysfunctions and provide a noninvasive biomarker suitable for monitoring targeted drug therapies in these ASD/AEP patients \[[@CIT0011]\].
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